S. V. Morant

6.5k total citations · 1 hit paper
98 papers, 4.2k citations indexed

About

S. V. Morant is a scholar working on Agronomy and Crop Science, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S. V. Morant has authored 98 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Agronomy and Crop Science, 26 papers in Genetics and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S. V. Morant's work include Reproductive Physiology in Livestock (26 papers), Genetic and phenotypic traits in livestock (18 papers) and Ruminant Nutrition and Digestive Physiology (16 papers). S. V. Morant is often cited by papers focused on Reproductive Physiology in Livestock (26 papers), Genetic and phenotypic traits in livestock (18 papers) and Ruminant Nutrition and Digestive Physiology (16 papers). S. V. Morant collaborates with scholars based in United Kingdom, United States and Italy. S. V. Morant's co-authors include Thomas M. MacDonald, I. C. Hart, J. A. Bines, Isla S. Mackenzie, John Sutton, Jackie Salsbury, Mark J. Caulfield, Ian Ford, Morris J. Brown and Bryan Williams and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

S. V. Morant

96 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

2015 735 citations Bryan Williams, Thomas M. MacDonald et al. The Lancet profile →

Peers

Countries citing papers authored by S. V. Morant

Since Specialization

Citations

This map shows the geographic impact of S. V. Morant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. V. Morant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. V. Morant more than expected).

Fields of papers citing papers by S. V. Morant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. V. Morant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. V. Morant. The network helps show where S. V. Morant may publish in the future.

Co-authorship network of co-authors of S. V. Morant

This figure shows the co-authorship network connecting the top 25 collaborators of S. V. Morant. A scholar is included among the top collaborators of S. V. Morant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. V. Morant. S. V. Morant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study 2024 ·EClinicalMedicine ·Filippo Pigazzani, Kenneth A. Dyar, S. V. Morant, Céline Vetter, Amy Rogers, Robert Flynn, David Rorie, Isla S. Mackenzie, Francesco P. Cappuccio, Roberto Manfredini, Thomas M. MacDonald	12
2	Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study 2022 ·BMJ Open ·Amy Rogers, E. Douglas Rooke, S. V. Morant, Greg Guthrie, Alex S. F. Doney, Andrew Duncan, Isla S. Mackenzie, R.J. Barr, Filippo Pigazzani, (unknown), Thomas M. MacDonald	9
3	Dietary nitrate prevents progression of carotid subclinical atherosclerosis through blood pressure‐independent mechanisms in patients with or at risk of type 2 diabetes mellitus 2021 ·British Journal of Clinical Pharmacology ·Franca Morselli, Luca Faconti, Charlotte Mills, S. V. Morant, Phil Chowienczyk, Joshua Au Yeung, Alessandro Cavarape, J. CRUICKSHANK, David J. Webb	4
4	Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension 2021 ·Trials ·Amy Rogers, (unknown), Isla S. Mackenzie, (unknown), R.J. Barr, Robert Flynn, S. V. Morant, Thomas M. MacDonald, Alex S. F. Doney	2
5	Spironolactone use and risk of incident cancers: a retrospective, matched cohort study 2016 ·British Journal of Clinical Pharmacology ·Isla S. Mackenzie, S. V. Morant, Li Wei, Alastair M. Thompson, Thomas M. MacDonald	41
6	Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial breakdown → 2015 ·The Lancet ·Bryan Williams, Thomas M. MacDonald, S. V. Morant, David R. Webb, Peter Sever, Gordon T. McInnes, Ian Ford, J. CRUICKSHANK, Mark J. Caulfield, Jackie Salsbury, Isla S. Mackenzie, Sandosh Padmanabhan, Morris J. Brown	735
7	Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression 2013 ·PLoS ONE ·Sharmilee Gnanapavan, Donna Grant, S. V. Morant, J Furby, Tom Hayton, Charlotte E. Teunissen, Valerio Leoni, Mónica Marta, Robert Brenner, Jacqueline Palace, David H. Miller, Raj Kapoor, Gavin Giovannoni	42
8	Investigation into the Value of Trained Glycaemia Alert Dogs to Clients with Type I Diabetes 2013 ·PLoS ONE ·Nicola J. Rooney, S. V. Morant, Claire Guest	62
9	Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD 2009 ·Thorax ·Stuart Schembri, S. V. Morant, J H Winter, Thomas M. MacDonald	74
10	Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom 2008 ·British Journal of Clinical Pharmacology ·Thomas M. MacDonald, S. V. Morant	17
11	Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK 2008 ·International Journal of Clinical Practice ·S. V. Morant, K Reilly, (unknown), Christopher R. Chapple	30
12	Switching statins : the impact on patient outcomes 2007 ·British Journal of Cardiology ·(unknown), Craig S. Roberts, Amy E. Rudolph, S. V. Morant, (unknown), Christopher O’Regan	42
13	Drug treatment discontinuation and achievement of target blood pressure and cholesterol in United Kingdom primary care 2007 ·Current Medical Research and Opinion ·Thomas M. MacDonald, S. V. Morant, Essy Mozaffari	6
14	Treatment patterns of hypertension and dyslipidaemia in hypertensive patients at higher and lower risk of cardiovascular disease in primary care in the United Kingdom 2007 ·Journal of Human Hypertension ·Thomas M. MacDonald, S. V. Morant, Essy Mozaffari	12
15	Application of a propensity score to adjust for channelling bias with NSAIDs 2004 ·Pharmacoepidemiology and Drug Safety ·S. V. Morant, Dan Pettitt, Thomas M. MacDonald, Thomas Burke, (unknown)	12
16	Rates of Production of Acetate, Propionate, and Butyrate in the Rumen of Lactating Dairy Cows Given Normal and Low-Roughage Diets 2003 ·Journal of Dairy Science ·John Sutton, M.S. Dhanoa, S. V. Morant, J. France, D. J. Napper, E Schuller	236
17	Emergency admissions for upper gastrointestinal disease and their relation to NSAID use 1997 ·Alimentary Pharmacology & Therapeutics ·A L Blower, Andrew I. Brooks, G C Fenn, Ashley E. Hill, (unknown), S. V. Morant, Karna Dev Bardhan	138
18	Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study 1997 ·BMJ ·Thomas M. MacDonald, S. V. Morant, Geoffrey C. Robinson, M Shield, Mark McGilchrist, Frank E. Murray, D. G. McDevitt	237
19	Consequences of diagnostic errors in mastitis therapy trials 1988 ·Journal of Dairy Research ·S. V. Morant, F. H. Dodd, R.P. Natzke	11
20	Metabolic role of growth hormone in lactating cattle. 1980 ·Journal of Endocrinology ·I. C. Hart, J. A. Bines, S. V. Morant	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact